American States Where Cannabis Is Illegal See Higher Use of Synthetic Cannabinoids

In the wake of the 2018 Farm Bill legalizing hemp and its derivatives in the United States, the market for cannabinoids derived from hemp has experienced unprecedented growth. Notably, delta-8 THC, a less potent but still psychoactive compound, has gained considerable popularity, offering an alternative to those seeking a legal high.

This trend, particularly evident in states that have not adopted comprehensive cannabis reform measures, was recently the focus of a study published by the American Medical Association (AMA). It highlights the impact of cannabis prohibition on the increase in synthetic cannabinoid use.

The Landscape of Hemp-Derived Cannabinoids

Supported by the AMA, the study conducted by the University of Michigan, the University of Buffalo, and the Legacy Research Institute examined trends in lesser-known cannabinoids like delta-8 THC, CBG, and CBN, while also assessing CBD use. Conducted in June 2023 with 1,169 adults, the study looked at the use and awareness of these cannabinoids over the past year.

According to the study, 26.3% of participants reported using cannabis in the past year, and 71.7% were familiar with CBD. Delta-8 THC, CBG, and CBN were known to 41.2%, 18.4%, and 16.8% of participants, respectively. Data revealed a 50% increase in CBD consumption over the past four years, facilitated by the 2018 Farm Bill.

Delta-8 THC emerged as a notable player, with 11.9% of participants reporting its use in the past year. The study also found that 25.2% of participants had used an emerging cannabinoid in the past year. Interestingly, residing in American states with cannabis laws negatively correlates with delta-8 THC use, suggesting that legal access to THC-based cannabis products may deter consumers from exploring synthetic hemp-derived alternatives.

Impact of Cannabis Prohibition on Delta-8 THC

The study posits that cannabis prohibition inadvertently promotes the popularity of delta-8-THC, a cannabinoid naturally occurring in minute quantities and thus synthesized in laboratories from CBD. The authors note that delta-8-THC use is more prevalent in states without medical or adult-use cannabis laws, suggesting that legal restrictions inadvertently drive consumers toward this synthetic cannabinoid. People living in states without recreational cannabis laws were more than twice as likely to have used delta-8 THC in the past year.

The study’s authors emphasize the significance of these findings: “Higher delta-8 THC use in states without medical or adult-use cannabis laws suggests that cannabis prohibition may inadvertently promote delta-8 THC use.”

This observation raises concerns about the unintended consequences of cannabis prohibition, particularly among younger age groups, where cannabis use in the past year was more common.

The study acknowledges the lack of controlled human studies on neocannabinoids but emphasizes that survey data indicate these products are commonly used to treat sleep or pain, replacing other pharmaceuticals. In light of these findings, the authors advocate for continued public health surveillance efforts to monitor new cannabinoids due to the absence of industry standards and the potentially similar effects of delta-8 THC and its hemp-derived equivalents to delta-9 THC.

The Drug Enforcement Administration (DEA) has also weighed in, stating that synthetic cannabinoids are prohibited. A recent 2023 revelation confirmed that delta-8 THC synthesized from legal CBD is considered a controlled substance prohibited by the DEA. The issue is expected to be addressed directly in the next version of the Farm Bill, initially scheduled for this year but now postponed to 2024.

—

(Featured image by TX Attorney General (CC BY-ND 2.0) via Flickr)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Newsweed, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.